Executive Wealth Management LLC boosted its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 14.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 84,106 shares of the technology company's stock after acquiring an additional 10,466 shares during the period. Executive Wealth Management LLC owned 0.07% of Amdocs worth $7,358,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Janus Henderson Group PLC raised its stake in shares of Amdocs by 1.7% during the third quarter. Janus Henderson Group PLC now owns 6,625,875 shares of the technology company's stock worth $579,632,000 after purchasing an additional 111,357 shares during the last quarter. Pzena Investment Management LLC increased its stake in Amdocs by 12.3% in the 3rd quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company's stock valued at $556,700,000 after buying an additional 696,136 shares during the period. LSV Asset Management raised its position in Amdocs by 7.9% during the 2nd quarter. LSV Asset Management now owns 3,207,155 shares of the technology company's stock worth $253,109,000 after buying an additional 234,096 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Amdocs by 36.6% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company's stock worth $277,818,000 after acquiring an additional 851,022 shares during the period. Finally, Brandes Investment Partners LP boosted its holdings in shares of Amdocs by 31.1% in the second quarter. Brandes Investment Partners LP now owns 2,260,811 shares of the technology company's stock valued at $178,335,000 after acquiring an additional 536,359 shares in the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research firms recently issued reports on DOX. Stifel Nicolaus initiated coverage on shares of Amdocs in a report on Wednesday, October 2nd. They set a "buy" rating and a $100.00 price target for the company. Barclays reduced their price target on Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a report on Thursday, November 14th. StockNews.com lowered Amdocs from a "strong-buy" rating to a "buy" rating in a report on Thursday, November 14th. Finally, Oppenheimer raised their target price on Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Amdocs currently has an average rating of "Moderate Buy" and a consensus price target of $101.20.
Check Out Our Latest Stock Analysis on Amdocs
Amdocs Price Performance
NASDAQ DOX traded down $0.61 during mid-day trading on Tuesday, hitting $86.07. The stock had a trading volume of 720,430 shares, compared to its average volume of 678,230. The company has a 50 day simple moving average of $88.08 and a 200 day simple moving average of $84.37. The company has a market cap of $10.12 billion, a price-to-earnings ratio of 20.30, a P/E/G ratio of 1.44 and a beta of 0.72. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $94.04. The company has a quick ratio of 1.24, a current ratio of 1.20 and a debt-to-equity ratio of 0.21.
Amdocs Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.479 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.23%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs's dividend payout ratio (DPR) is presently 45.28%.
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.